Med BioGene - News Archives 2007

Featured News

February 17, 2010

Med BioGene Announces Results of Annual and Special Meeting

January 20, 2010

Med BioGene Announces Date of Annual and Special Meeting and Adoption of Shareholder Rights Plan

January 18, 2010

Med BioGene Appoints World-Renowned Genticist Dr. Michael R. Hayden as Director

December 29, 2009

Med BioGene Files Registration Statement for Proposed U.S. IPO

December 03, 2009

Med BioGene Announces Poster Presentations of LungExpress Dx™ Validation Study and Health Economics Evaluation at AACR – IASLC Meeting in January

October 15, 2009

Med BioGene Announces Positive Results from Validation Study of LungExpess Dx™

August 17, 2009

Med BioGene Reports Financial Results for the Second Quarter 2009

July 16, 2009

Med BioGene and the University of Ottawa Heart Institute Publish Study Demonstrating Potential New Diagnostic and Therapeutic Gene Expression Markers for Coronary Artery Disease

July 14, 2009

Med BioGene Increases Private Placement

June 25, 2009

Med BioGene Announces Closing of Second Tranche of Private Placement

June 05, 2009

Med BioGene Announces Closing of First Tranche of Private Placement

April 22, 2009

Med BioGene Announces Private Placement and Lead Order

March 18, 2009

Med BioGene Expands Collaboration with University Health Network for Novel Gene Markers Predictive of Chemotherapy Response in Lung Cancer

March 16, 2009

Med BioGene Appoints Life Science Veteran as Chief Financial Officer

News Archives

2007

News Archives 2007

November 28, 2007

Med BioGene Reports Financial Results For The Third Quarter 2007

October 25, 2007

Med BioGene Engages U.S. Consulting Firm to Drive Partnering Efforts

September 24, 2007

Med BioGene Appoints Dr. Melanie M. Mahtani as Executive Advisor, Commercial Development

September 12, 2007

Med BioGene Inc. Welcomes Renowned Expert to Lymphoma Collaboration

September 10, 2007

Med BioGene Inc. Engages Peterson Capital to Provide Investor and Financial Relations Services

August 29, 2007

Med BioGene Inc. Reports Financial Results for the Second Quarter 2007

July 30, 2007

Med BioGene Inc. Dr. Nathan Yoganathan, President and Chief Scientific Officer, Transitions to Senior Advisory Role; Dr. Bradley McLean Appointed Chief Scientific Officer

June 29, 2007

Med BioGene Inc. Closes Second and Final Tranche of Private Placement

June 18, 2007

Med BioGene Inc. to Close Second and Final Tranche of Private Placement on June 29, 2007

June 01, 2007

Med BioGene Inc. Announces Closing of Private Placement

May 28, 2007

Med BioGene Inc. Reports Financial Results for the First Quarter 2007

March 27, 2007

Med BioGene Announces Private Placement

March 19, 2007

Med BioGene Announces Collaboration to Develop Genetic Biomarkers for Lymphoma and Leukemia for use in Diagnosis, Prognosis and Drug Development

February 27, 2007

Med BioGene Appoints Dr. Richard C. Cook to its Scientific Advisory Board

February 15, 2007

Med BioGene Enters Development Phase For Genetic Screening Test For Colorectal Cancer

February 15, 2007

Med BioGene Engages The Howard Group Inc. to Provide Investor and Financial Relations Services

February 08, 2007

Med BioGene Receives $307,000 Contribution from National Research Council Canada to Develop Genetic Biomarkers for Cardiovascular Disease

February 01, 2007

Med BioGene Announces Further Promising Results on the Diagnostic Value of its Lymphoma Genetic Biomarkers

E-MAIL ALERTS

Subscribe to our e-mail news alerts